Tekcapital's Belluscura Asks For US FDA Clearance On Oxygen Carrier

(Alliance News) - Tekcapital PLC on Thursday announced Texas-based portfolio company Belluscura ...

Alliance News 3 December, 2020 | 11:11AM
Email Form

(Alliance News) - Tekcapital PLC on Thursday announced Texas-based portfolio company Belluscura requested clearance from the US Food and Drug Administration for its portable oxygen concentrator.

Tekcapital is a London-based intellectual property investment group focused on university technology.

Tekcapital noted that the X-PLO2R portable oxygen concentrator's clearance does not have a specific timetable but its use as a Covid-19 treatment has given it a priority review.

Tekcapital Executive Chair Clifford Gross said: "We are very glad to see that Belluscura has filed an application with the FDA requesting clearance of their X-PLO2R portable oxygen concentrator. Belluscura believes that their new device could be helpful to patients during the Covid-19 pandemic, and for the 250 million people worldwide suffering from chronic obstructive pulmonary disease."

Tekcapital owns 18% of Belluscura.

Tekcapital shares were up 15% at 14.89 pence each in London on Thursday morning.

By Greg Roxburgh; gregroxburgh@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Email Form

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Tekcapital PLC 18.00 GBX 9.09 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

Audience Confirmation


By clicking 'accept' I acknowledge that this website uses cookies and other technologies to tailor my experience and understand how I and other visitors use our site. See 'Cookie Consent' for more detail.

  • Other Morningstar Websites
© Copyright 2020 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies